Loading clinical trials...
Loading clinical trials...
Safety and Efficacy of Oral Hyoscine Butylbromide Versus Topical EMLA Spray in Reducing Pain During Hysterosalpingography: A Randomized Double-Blind Placebo-Controlled Trial
Conditions
Interventions
Oral Hyoscine butylbromide and Placebo Spray
Topical EMLA Spray and Placebo Oral Tablet
+1 more
Locations
1
Egypt
Al Gezeera Hospital
Giza, Egypt
Start Date
October 3, 2025
Primary Completion Date
March 1, 2026
Completion Date
March 30, 2026
Last Updated
February 3, 2026
Lead Sponsor
Cairo University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions